TwoStep Therapeutics
Developing peptide-based targeted cancer therapies for patients with solid tumors
Highlights
- New on EvolcAdded 2026-11-14
About TwoStep Therapeutics
TwoStep Therapeutics is developing therapies based on a peptide that binds multiple tumor-associated targets, enabling delivery of different payloads across solid tumor types. Its pipeline includes peptide-drug conjugate and radioligand programs.
The company launched in 2024 as a biotechnology spinout based on research developed at Stanford. It is hiring for a full-time role in the San Francisco Bay Area.
Product: A pipeline of peptide-based drug conjugate and radioligand therapies targeting solid tumors.
Jobs at TwoStep Therapeutics
More biotech & pharma companies
Valo Health
AI-enabled drug discovery and development for pharmaceutical and biotech partnersNew on EvolcVaxart
Develops oral pill vaccines for infectious diseases for public health and healthcare marketsNew on EvolcVaxcyte
Clinical-stage vaccine developer making pneumococcal, Group A Strep and Shigella vaccines for children and at-risk adultsRemote-friendlyVerastem
Develops and commercializes targeted cancer therapies for patients with RAS/MAPK pathway-driven cancersNew on EvolcViatris
Global pharmaceutical company supplying generic, branded and innovative medicines to patients and healthcare markets worldwideVilya
AI-driven drug design company creating novel macrocycle therapeutics for diseases with limited treatment optionsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Recruiting
- AshbyMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.